NCT04165746 (EI-3) is a NA clinical trial of Foster Care in Socioemotional Development, sponsored by Boston Children's Hospital.

Who is sponsoring NCT04165746?

NCT04165746 is sponsored by Boston Children's Hospital.

What drugs are being tested in NCT04165746?

Interventions in NCT04165746: Foster Care, Caregiving Intervention.

What condition does NCT04165746 study?

NCT04165746 studies Socioemotional Development, Cognitive Ability, Behavioral and Neural Patterns of Attention, Brain Function, Psychopathology.

Is NCT04165746 still recruiting?

NCT04165746 is currently recruiting now. Last updated 18 March 2026.

Last reviewed 2026-03-18 · How we verify

NCT04165746: EI-3

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Institutionalization Intervention Impact Project

Recruiting now NA Last updated 18 March 2026

What this trial tests

NA trial testing Foster Care in Socioemotional Development in 220 participants. Currently enrolling.

Timeline

16 March 2023

Primary endpoint
31 March 2028

31 March 2029

Quick facts

Lead sponsor	Boston Children's Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	220
Start date	16 March 2023
Primary completion	31 March 2028
Estimated completion	31 March 2029
Sites	1 location across Brazil

Drugs / interventions tested

Foster Care
Caregiving Intervention

Conditions studied

Socioemotional Development — all drugs for Socioemotional Development →
Cognitive Ability — all drugs for Cognitive Ability →
Behavioral and Neural Patterns of Attention — all drugs for Behavioral and Neural Patterns of Attention →
Brain Function — all drugs for Brain Function →

Sponsor

Boston Children's Hospital

Who can join

Under 24 Months, any sex, with Socioemotional Development or Cognitive Ability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the effects of early intervention (placement into foster care, and a caregiving training) on physical, cognitive, social and brain development and psychiatric symptomatology in children place in out-of-home care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Boston Children's Hospital trials

Trials by the same sponsor.

NCT06804382 — Academic Detailing to Optimize PrEP Implementation in Pediatric Primary Care Settings: ADOPT-PrEP · NA · not yet recruiting
NCT05113394 — Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy · Phase 2 · withdrawn
NCT06434220 — Effect of Predictive Model on ED Physician Assessments of Patient Disposition · NA · not yet recruiting
NCT07476430 — Readiness Outcomes Affecting Return to Sport 3.0 · NA · not yet recruiting
NCT06706336 — Radon Asthma Intervention Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04165746 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boston Children's Hospital
Last refreshed: 18 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04165746.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing